RecruitingNot ApplicableNCT06100172

Transcutaneous Auricular Neurostimulation After Lumbar Surgery

Delivering Transcutaneous Auricular Neurostimulation as an Adjunct Non-Opioid Pain Management Therapy for Patients Undergoing Lumbar Surgery


Sponsor

University of Texas Southwestern Medical Center

Enrollment

20 participants

Start Date

Oct 29, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study, entitled "Delivering Transcutaneous Auricular Neurostimulation as an Adjunct Non-Opioid Pain Management Therapy for Patients Undergoing Lumbar Surgery", is to demonstrate whether transcutaneous auricular neurostimulation (tAN) can non-invasively reduce the perception of pain in patients undergoing lumbar surgery. tAN is placed on and around the ear to non-invasively stimulate branches of the vagus and trigeminal nerves and modulate specific brain regions associated with pain.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Inclusion Criteria4

  • Medically cleared to undergo a lumbar spine surgery, either spinal fusion with or without multilevel laminectomies, or lumbar multilevel laminectomies alone.
  • years of age
  • English Proficiency
  • Participants must be able to provide informed consent and function at an intellectual level sufficient for study requirements

Exclusion Criteria11

  • Current evidence of an uncontrolled and/or clinically significant medical condition
  • History of bleeding disorders or coagulopathy
  • History of seizures or epilepsy
  • History of neurological diseases or traumatic brain injury
  • Use of illegal recreational drugs
  • Presence of devices, e.g. pacemakers, cochlear prosthesis, neuro-stimulators
  • Use of acupuncture within 4 weeks of surgery
  • Grossly abnormal external ear anatomy or active ear infection
  • Women of childbearing potential, not using effective contraception per investigator judgment or not willing to comply with contraception for the duration of the study
  • Females who are pregnant or lactating
  • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESparrow Ascent Transcutaneous Auricular Neurostimulation (tAN)

This method of simultaneous vagal and trigeminal stimulation via the external ear is known as transcutaneous auricular neurostimulation (tAN), as the targets of electrical stimulation include the auricular branch of the vagus nerve (ABVN) and auriculotemporal nerve (ATN), which is a branch of the mandibular division of the trigeminal nerve. Electrodes applied to select dermatome regions can target ear neural structures and deliver non-invasive vagus nerve stimulation (VNS) and trigeminal nerve stimulation (TNS). Use of tAN for pain relief is an attractive alternative to pharmacologic and opioid-based approaches because it is safe and effective and presents no addiction liability.

DEVICESham Control Device

This device looks like the active device, but no stimulation will be delivered.


Locations(1)

UT Southwestern Medical Center

Dallas, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06100172


Related Trials